BETter together: exploiting BRD4-functions in transcription to inform rational combinations
Oncoscience
.
2018 Jun 23;5(5-6):122-123.
doi: 10.18632/oncoscience.415.
eCollection 2018 May.
Authors
Fabio Savarese
1
,
Norbert Kraut
1
Affiliation
1
Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
PMID:
30035159
PMCID:
PMC6049308
DOI:
10.18632/oncoscience.415
No abstract available
Keywords:
BET inhibitors; BRD4; CDK9; PARP; drug combinations.
Publication types
Editorial